Thalidomide induces complete response in cutaneous lupus
(HealthDay) -- Low-dose thalidomide successfully induces complete response in a majority of patients with refractory cutaneous lupus erythematosus (CLE), according to research published in the March issue of the British Journal ...
Mar 1, 2012
0
0